search
Back to results

Spontaneous Atrio Ventricular Conduction Preservation (SAVER)

Primary Purpose

Sinus Node Dysfunction, Bradycardia-Tachycardia Syndrome, Paroxysmal Atrioventricular Block

Status
Completed
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
Symphony D 2450
Symphony DR 2550
Sponsored by
LivaNova
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sinus Node Dysfunction focused on measuring Pacing, AV conduction disorders, minimized ventricular pacing, AF

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient has been primo-implanted with a Symphony™ 2550 or 2450 devices for less than 3 months
  • Patient with a normal spontaneous AV conduction at rest (PR < 250 ms)
  • Patient implanted for Sinus Node Dysfunction, Braycardia-Tachycardia Syndrome, carotid sinus syndrome/ vaso vagal syndrome or paroxistic AV Block
  • Patient implanted with a bipolar right-atrial lead and ventricular lead available in the local market
  • Patient has signed a consent form after having received the appropriate information

Exclusion Criteria:

  • Permanent 1st, 2nd or 3rd AV block
  • Patient having a medical status complying with one of the following cases
  • patient suffering from sustained ventricular arrhythmias
  • patient having sustained a myocardial infarction within the last month
  • patient having undergone cardiac surgery within the last month
  • patient suffering from severe aortic stenosis
  • patient suffering from unstable angina pectoris
  • patient presents with permanent atrial arrhythmias
  • Patient is not able to understand the study objectives and protocol or refuses to co-operate
  • Patient is not available for scheduled follow-up
  • Patient has a life expectancy less than one year
  • Patient is included into another clinical study
  • Patient is minor or a pregnant woman

Sites / Locations

  • Onze lieve Vrouw ziekenhuis
  • Clinique Louis Caty
  • Hôpital universitaire Brugmann
  • Europa ziekenhuis
  • Heiling Hart van Jezus
  • Hôpital Vésale (univ.)
  • CHU - Tivoli
  • Centre Hospitalier
  • CH Albi
  • CHU d'Angers
  • CHU Jean Minjoz
  • CH de CASTRES
  • Hospice St-Jacques-Hôspital G.Montpied
  • CHU - Hopital Michallon
  • CHRU de Lille - Hôpital Cardiologique
  • CHU de Limoges
  • CH Montpellier
  • CH Emile Muller
  • CHU de Nantes
  • Nouvelles Cliniques Nantaises
  • CHU de Nice
  • Clinique Bizet
  • CHU Pontchaillou
  • CHU Hopital C. Nicolle
  • InParys Cardiology
  • CHU de Nancy
  • Marien Hospital
  • Universitätskliniken Bonn
  • St.Josef-Stift Bremen
  • St. Salvator Krankenhaus Halberstadt
  • Holzminden Praxis Bub
  • Hürth Sana
  • Herzzentrum Kassel
  • KH Holweide
  • Klinikum Lüdenscheid
  • Universitätsklinikum Schleswig-Holstein
  • Städt. Kh. Lüneburg
  • Univ. Mainz
  • Univ. Marburg
  • Klinkum Memmingen
  • Augustinum
  • Klinikum Bogenhausen
  • Rot-Kreuz Krankenhaus
  • Praxis Bitar
  • Uni Regensburg
  • Prof. Frey Praxis Starnberg
  • Uni Ulm
  • Waren-Müritzklinikum
  • Klinikum Wolgast
  • Ospedale Moscati
  • Ospedale Mellini
  • Ospedale Civile
  • Ospedale S. G. Battista
  • Ospedale Umberto I
  • Ospedale Civile
  • Istituto Policlinico
  • Ospedale Civile
  • Ospedale Civile
  • Ospedale Civili Reuniti
  • Ospedale Civile
  • Queen Elizabeth Hospital
  • Bristol Royal Infirmary
  • Queens Hospital
  • Castle Hill Hospital
  • Leeds General Infirmary
  • Barts and The London NHS Trust
  • St Thomas' Hospital,

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Other

Arm Label

1

2

3

4

Arm Description

AAISafeR mode programming

DDD with long AV Delay programming

DDDAMC mode programming

AAISafer mode programming in non randomized patients

Outcomes

Primary Outcome Measures

mean percentage of ventricular pacing between the randomized branches on a two-months period (M3 visit)
mean percentage of ventricular pacing between the studied groups during the whole study (up to 1 year).

Secondary Outcome Measures

percentage of ventricular pacing two month after randomization versus the percentage reported at the end of the first month follow-up in AAIsafeR mode.
AF burden relatively to the branch of the protocol
evolution of conduction disturbances by documentings nature, number and duration of ario-ventricular blocks.

Full Information

First Posted
April 1, 2008
Last Updated
April 3, 2008
Sponsor
LivaNova
search

1. Study Identification

Unique Protocol Identification Number
NCT00655213
Brief Title
Spontaneous Atrio Ventricular Conduction Preservation
Acronym
SAVER
Official Title
Spontaneous Atrio Ventricular Conduction Preservation
Study Type
Interventional

2. Study Status

Record Verification Date
April 2008
Overall Recruitment Status
Completed
Study Start Date
November 2003 (undefined)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
LivaNova

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In case of sinus node dysfunction, it is often necessary to choose the safer option provided by a DDD pacemaker even though the most appropriate mode of pacing is AAI mode. In addition to saving energy, the latter mode allows spontaneous ventricular activation, the haemodynamic consequences of which are, in most cases, better than those obtained with dual chamber pacing. Recent studies as the MOST study suggest also that ventricular desynchronization imposed by right ventricular apical pacing even when AV synchrony is preserved increases the risk of atrial fibrillation in patients with SND. Similar results were already given by anterior studies (PIPAF) which, taking into account the percentage of ventricular pacing, suggested that AF prevention algorithm in combination with a preserved native conduction are efficient in reducing AF burden. However, current practice is to implant a dual chamber pacemaker to prevent the risk of atrioventricular block (AVB) even if DDDR pacing with a fixed long AV delay was found inefficient in reducing ventricular pacing and was associated with a high risk of arrhythmias. The Symphony 2550 cardiac pacemaker offers pacing modes that automatically switch from AAI(R) mode to DDD(R) or DDI(R) in event of severe atrioventricular conduction disorder, irrespective of whether or not these are accompanied by an atrial arrhythmia, returning spontaneously to AAI(R) mode as soon as the spontaneous AV conduction has resumed. These 2 particular modes are called the AAI SafeR and DDD/AMC (R) mode. The main differences between both modes are that (i) AAI SafeR does not trigger any AV Delay after a sensed or paced atrial event which allows long PR intervals or even limited ventricular pauses with no switch to DDD(R), while (ii) DDD/AMC (R) is able to optimize AV Delay after switching to DDD(R) according to measured spontaneous conduction times and to provide an acceleration in case of vaso-vagal syndrome. This pacing mode has previously been assessed in clinical studies. This study intends to demonstrate that the automatic modes switching significantly reduce the percentage of ventricular pacing in patients implanted with a spontaneous AV conduction and reduce the occurrence of atrial arrhythmias, on a mid-term follow-up period, in comparison to standard DDD pacing with long AVDelay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sinus Node Dysfunction, Bradycardia-Tachycardia Syndrome, Paroxysmal Atrioventricular Block
Keywords
Pacing, AV conduction disorders, minimized ventricular pacing, AF

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
622 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
AAISafeR mode programming
Arm Title
2
Arm Type
Active Comparator
Arm Description
DDD with long AV Delay programming
Arm Title
3
Arm Type
Active Comparator
Arm Description
DDDAMC mode programming
Arm Title
4
Arm Type
Other
Arm Description
AAISafer mode programming in non randomized patients
Intervention Type
Device
Intervention Name(s)
Symphony D 2450
Intervention Type
Device
Intervention Name(s)
Symphony DR 2550
Primary Outcome Measure Information:
Title
mean percentage of ventricular pacing between the randomized branches on a two-months period (M3 visit)
Time Frame
2 months
Title
mean percentage of ventricular pacing between the studied groups during the whole study (up to 1 year).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
percentage of ventricular pacing two month after randomization versus the percentage reported at the end of the first month follow-up in AAIsafeR mode.
Time Frame
12 months
Title
AF burden relatively to the branch of the protocol
Time Frame
12 months
Title
evolution of conduction disturbances by documentings nature, number and duration of ario-ventricular blocks.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient has been primo-implanted with a Symphony™ 2550 or 2450 devices for less than 3 months Patient with a normal spontaneous AV conduction at rest (PR < 250 ms) Patient implanted for Sinus Node Dysfunction, Braycardia-Tachycardia Syndrome, carotid sinus syndrome/ vaso vagal syndrome or paroxistic AV Block Patient implanted with a bipolar right-atrial lead and ventricular lead available in the local market Patient has signed a consent form after having received the appropriate information Exclusion Criteria: Permanent 1st, 2nd or 3rd AV block Patient having a medical status complying with one of the following cases patient suffering from sustained ventricular arrhythmias patient having sustained a myocardial infarction within the last month patient having undergone cardiac surgery within the last month patient suffering from severe aortic stenosis patient suffering from unstable angina pectoris patient presents with permanent atrial arrhythmias Patient is not able to understand the study objectives and protocol or refuses to co-operate Patient is not available for scheduled follow-up Patient has a life expectancy less than one year Patient is included into another clinical study Patient is minor or a pregnant woman
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean Marc DAVY, PhD
Organizational Affiliation
CH Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
Onze lieve Vrouw ziekenhuis
City
Aalst
Country
Belgium
Facility Name
Clinique Louis Caty
City
Baudour
Country
Belgium
Facility Name
Hôpital universitaire Brugmann
City
Bruxelles
Country
Belgium
Facility Name
Europa ziekenhuis
City
Campus st. Elisabeth Uccle
Country
Belgium
Facility Name
Heiling Hart van Jezus
City
Moen
Country
Belgium
Facility Name
Hôpital Vésale (univ.)
City
Montigny Le Tilleul
Country
Belgium
Facility Name
CHU - Tivoli
City
Tivoli
Country
Belgium
Facility Name
Centre Hospitalier
City
Aix-en-Provence
Country
France
Facility Name
CH Albi
City
Albi
Country
France
Facility Name
CHU d'Angers
City
Angers
Country
France
Facility Name
CHU Jean Minjoz
City
Besancon
Country
France
Facility Name
CH de CASTRES
City
Castres-mazamet
Country
France
Facility Name
Hospice St-Jacques-Hôspital G.Montpied
City
Clermont-Ferrand
Country
France
Facility Name
CHU - Hopital Michallon
City
Grenoble
ZIP/Postal Code
38043
Country
France
Facility Name
CHRU de Lille - Hôpital Cardiologique
City
Lille
Country
France
Facility Name
CHU de Limoges
City
Limoges
Country
France
Facility Name
CH Montpellier
City
Montpellier
Country
France
Facility Name
CH Emile Muller
City
Mulhouse
Country
France
Facility Name
CHU de Nantes
City
Nantes
Country
France
Facility Name
Nouvelles Cliniques Nantaises
City
Nantes
Country
France
Facility Name
CHU de Nice
City
Nice
Country
France
Facility Name
Clinique Bizet
City
Paris cedex 16
ZIP/Postal Code
75116
Country
France
Facility Name
CHU Pontchaillou
City
Rennes
Country
France
Facility Name
CHU Hopital C. Nicolle
City
Rouen
ZIP/Postal Code
76035
Country
France
Facility Name
InParys Cardiology
City
St Cloud
Country
France
Facility Name
CHU de Nancy
City
Vandoeuvre les Nancy
ZIP/Postal Code
54511
Country
France
Facility Name
Marien Hospital
City
Bonn
Country
Germany
Facility Name
Universitätskliniken Bonn
City
Bonn
Country
Germany
Facility Name
St.Josef-Stift Bremen
City
Bremen
Country
Germany
Facility Name
St. Salvator Krankenhaus Halberstadt
City
Halberstadt
Country
Germany
Facility Name
Holzminden Praxis Bub
City
Holzminden
Country
Germany
Facility Name
Hürth Sana
City
Hürth
Country
Germany
Facility Name
Herzzentrum Kassel
City
Kassel
Country
Germany
Facility Name
KH Holweide
City
Koln
Country
Germany
Facility Name
Klinikum Lüdenscheid
City
Luedenscheid
Country
Germany
Facility Name
Universitätsklinikum Schleswig-Holstein
City
Lübeck
Country
Germany
Facility Name
Städt. Kh. Lüneburg
City
Lüneburg
Country
Germany
Facility Name
Univ. Mainz
City
Mainz
Country
Germany
Facility Name
Univ. Marburg
City
Marburg
Country
Germany
Facility Name
Klinkum Memmingen
City
Memmingen
Country
Germany
Facility Name
Augustinum
City
Munchen
Country
Germany
Facility Name
Klinikum Bogenhausen
City
Munchen
Country
Germany
Facility Name
Rot-Kreuz Krankenhaus
City
Munchen
Country
Germany
Facility Name
Praxis Bitar
City
Peine
Country
Germany
Facility Name
Uni Regensburg
City
Regensburg
Country
Germany
Facility Name
Prof. Frey Praxis Starnberg
City
Starnberg
Country
Germany
Facility Name
Uni Ulm
City
Ulm
Country
Germany
Facility Name
Waren-Müritzklinikum
City
Waren
Country
Germany
Facility Name
Klinikum Wolgast
City
Wolgast
Country
Germany
Facility Name
Ospedale Moscati
City
Avellino
Country
Italy
Facility Name
Ospedale Mellini
City
Chiari (BS)
Country
Italy
Facility Name
Ospedale Civile
City
Conegliano (TV)
Country
Italy
Facility Name
Ospedale S. G. Battista
City
Foligno (PG)
Country
Italy
Facility Name
Ospedale Umberto I
City
Mestre (VE)
Country
Italy
Facility Name
Ospedale Civile
City
Portogruaro (VE)
Country
Italy
Facility Name
Istituto Policlinico
City
San Donato
Country
Italy
Facility Name
Ospedale Civile
City
Sesto S. Giovanni (MI)
Country
Italy
Facility Name
Ospedale Civile
City
Trento
Country
Italy
Facility Name
Ospedale Civili Reuniti
City
Venezia
Country
Italy
Facility Name
Ospedale Civile
City
Voghera
Country
Italy
Facility Name
Queen Elizabeth Hospital
City
Birmingham
Country
United Kingdom
Facility Name
Bristol Royal Infirmary
City
Bristol
Country
United Kingdom
Facility Name
Queens Hospital
City
Burton on Trent
Country
United Kingdom
Facility Name
Castle Hill Hospital
City
Hull
Country
United Kingdom
Facility Name
Leeds General Infirmary
City
Leeds
Country
United Kingdom
Facility Name
Barts and The London NHS Trust
City
London
Country
United Kingdom
Facility Name
St Thomas' Hospital,
City
London
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Spontaneous Atrio Ventricular Conduction Preservation

We'll reach out to this number within 24 hrs